Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kalvista Pharmaceuticals (KALV) Q1 2024 Earnings
KALV
11
Mar
Confirmed
Q2 2023
Q2 2023
Q3 2023
Q1 2024
-0.94
-0.87
-0.81
-0.74
Details
Expected EPS
-0.747167
Actual EPS
-0.84
Surprise EPS
-0.09
Surprise Percent
+12.42%
Description
Kalvista Pharmaceuticals (KALV) has reported earnings of -0.84 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login